Affiliation:
1. Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, 1900 North 12th Street, 015-96, Room 203, Philadelphia, PA 19122, USA
Abstract
Polyomavirus BK (BKV) is a serious problem for immunocompromised patients, where latent virus can enter into the lytic cycle causing cytolytic destruction of host cells. BKV infects >80 % of the population worldwide during childhood and then remains in a latent state in the kidney. In the context of immunosuppression in kidney transplant patients, reactivation of the viral early promoter (BKVE) results in production of T antigen, enabling virus replication and transition from latency to the lytic phase, causing polyomavirus-associated nephropathy. Reactivation of BKV can also cause complications such as nephritis, atypical retinitis and haemorrhagic cystitis in AIDS patients. Here, the effects of human immunodeficiency virus type 1 (HIV-1) proteins Tat and Vpr on BKV transcription were investigated and it was demonstrated that Tat dramatically stimulated BKVE. Site-directed mutagenesis analysis of potential Tat-responsive transcriptional motifs complemented by an electrophoretic mobility shift assay (EMSA) showed that Tat activated BKVEby inducing binding of the NF-κB p65 subunit to aκB motif near the 3′ end of BKVE. In addition, a sequence within the 5′ UTR of BKVEtranscripts (BKVE-TAR) was identified that is identical to the HIV-1 transactivation response (TAR) element. The BKVE-TAR sequence bound TAT in RNA EMSA assays and deletion of the BKVE-TAR sequence eliminated Tat transactivation of BKVEtranscription. Thus, Tat positively affected BKVEtranscription by a dual mechanism and this may be important in diseases involving BKV reactivation in AIDS patients.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献